Deep Learning-Based Algorithms in Screening of Diabetic Retinopathy: A Systematic Review of Diagnostic Performance
- PMID: 31014679
- DOI: 10.1016/j.oret.2018.10.014
Deep Learning-Based Algorithms in Screening of Diabetic Retinopathy: A Systematic Review of Diagnostic Performance
Abstract
Topic: Diagnostic performance of deep learning-based algorithms in screening patients with diabetes for diabetic retinopathy (DR). The algorithms were compared with the current gold standard of classification by human specialists.
Clinical relevance: Because DR is a common cause of visual impairment, screening is indicated to avoid irreversible vision loss. Automated DR classification using deep learning may be a suitable new screening tool that could improve diagnostic performance and reduce manpower.
Methods: For this systematic review, we aimed to identify studies that incorporated the use of deep learning in classifying full-scale DR in retinal fundus images of patients with diabetes. The studies had to provide a DR grading scale, a human grader as a reference standard, and a deep learning performance score. A systematic search on April 5, 2018, through MEDLINE and Embase yielded 304 publications. To identify potentially missed publications, the reference lists of the final included studies were manually screened, yielding no additional publications. The Quality Assessment of Diagnostic Accuracy Studies 2 tool was used for risk of bias and applicability assessment.
Results: By using objective selection, we included 11 diagnostic accuracy studies that validated the performance of their deep learning method using a new group of patients or retrospective datasets. Eight studies reported sensitivity and specificity of 80.28% to 100.0% and 84.0% to 99.0%, respectively. Two studies report accuracies of 78.7% and 81.0%. One study provides an area under the receiver operating curve of 0.955. In addition to diagnostic performance, one study also reported on patient satisfaction, showing that 78% of patients preferred an automated deep learning model over manual human grading.
Conclusions: Advantages of implementing deep learning-based algorithms in DR screening include reduction in manpower, cost of screening, and issues relating to intragrader and intergrader variability. However, limitations that may hinder such an implementation particularly revolve around ethical concerns regarding lack of trust in the diagnostic accuracy of computers. Considering both strengths and limitations, as well as the high performance of deep learning-based algorithms, automated DR classification using deep learning could be feasible in a real-world screening scenario.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Deep learning algorithms for detection of diabetic retinopathy in retinal fundus photographs: A systematic review and meta-analysis.Comput Methods Programs Biomed. 2020 Jul;191:105320. doi: 10.1016/j.cmpb.2020.105320. Epub 2020 Jan 16. Comput Methods Programs Biomed. 2020. PMID: 32088490
-
Performance and Limitation of Machine Learning Algorithms for Diabetic Retinopathy Screening: Meta-analysis.J Med Internet Res. 2021 Jul 3;23(7):e23863. doi: 10.2196/23863. J Med Internet Res. 2021. PMID: 34407500 Free PMC article. Review.
-
Automated Identification of Diabetic Retinopathy Using Deep Learning.Ophthalmology. 2017 Jul;124(7):962-969. doi: 10.1016/j.ophtha.2017.02.008. Epub 2017 Mar 27. Ophthalmology. 2017. PMID: 28359545
-
Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.Acta Ophthalmol. 2018 Feb;96(1):63-68. doi: 10.1111/aos.13613. Epub 2017 Nov 27. Acta Ophthalmol. 2018. PMID: 29178249 Free PMC article.
-
Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning.Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5200-5206. doi: 10.1167/iovs.16-19964. Invest Ophthalmol Vis Sci. 2016. PMID: 27701631
Cited by
-
Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.BMJ. 2021 Sep 1;374:n1872. doi: 10.1136/bmj.n1872. BMJ. 2021. PMID: 34470740 Free PMC article.
-
Artificial Intelligence and Big Data in Diabetes Care: A Position Statement of the Italian Association of Medical Diabetologists.J Med Internet Res. 2020 Jun 22;22(6):e16922. doi: 10.2196/16922. J Med Internet Res. 2020. PMID: 32568088 Free PMC article.
-
Impact of Artificial Intelligence Assessment of Diabetic Retinopathy on Referral Service Uptake in a Low-Resource Setting: The RAIDERS Randomized Trial.Ophthalmol Sci. 2022 Apr 30;2(4):100168. doi: 10.1016/j.xops.2022.100168. eCollection 2022 Dec. Ophthalmol Sci. 2022. PMID: 36531575 Free PMC article.
-
Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review.Diagnostics (Basel). 2022 May 14;12(5):1234. doi: 10.3390/diagnostics12051234. Diagnostics (Basel). 2022. PMID: 35626389 Free PMC article. Review.
-
Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study.Clin Ophthalmol. 2022 Aug 17;16:2659-2667. doi: 10.2147/OPTH.S369675. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36003071 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous